A decade ago, pharmaceutical companies were focused primarily on generating data. Today, their biggest challenge is managing, integrating, and extracting […]
The pharmaceutical industry is facing a growing challenge. Nearly 70% to 90% of new drug candidates have poor water solubility,
The Cell and Gene Therapy (CGT) Market Dashboard which includes KPIs gives a clear view of how the CGT industry
Dental care often receives less attention than hospitals, medicines, or emergency healthcare. Yet in 2023, governments, insurers, dental companies, and
The relationship between Americans and pharmaceutical companies has always been complex. People rely on medicines every day, yet they also
Behavioral health clinics face a difficult challenge today. Clinicians want to spend more time helping patients, but administrative work such
For decades, diagnosing neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and ALS often meant waiting until symptoms became obvious.
The cell and gene therapy industry is entering a transformative phase, driven by breakthrough innovations in CAR-T therapies, gene editing,
For most pharmaceutical executives, the biggest challenge is no longer generating biological samples—it is managing them efficiently. Drug discovery programs,
The global melatonin supplement market experienced significant price fluctuations during 2025 and early 2026. While prices generally trended upward due